Banner Alzheimer's Institute Tucson

Tucson, Arizona 85718

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease

Studies at this site

• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217 — Completed
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Arizona Alzheimer's Disease Research Center (ADRC) — Status unconfirmed